| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.874 | 0.004 | 0.874 | Tubulin antagonist | 0.316 0.018 CID_154699576 | ||
| 0.85 | 0.005 | 0.85 | Caspase 9 stimulant | 0.832 0.007 CID_154699576 | ||
| 0.799 | 0.004 | 0.799 | Amyloid beta aggregation inhibitor | 0.488 0.015 CID_154699576 | ||
| 0.773 | 0.005 | 0.773 | Aldehyde oxidase inhibitor | |||
| 0.747 | 0.003 | 0.747 | Alpha tubulin antagonist | 0.074 0.022 CID_154699576 | ||
| 0.759 | 0.022 | 0.768 | Apoptosis agonist | 0.768 0.02 CID_154699576 | CID_154699576 | |
| 0.72 | 0.005 | 0.72 | Antimitotic | 0.422 0.02 CID_154699576 | ||
| 0.718 | 0.004 | 0.718 | Superoxide dismutase inhibitor | 0.206 0.111 CID_154699576 | ||
| 0.701 | 0.005 | 0.741 | Free radical scavenger | 0.741 0.005 CID_154699576 | CID_154699576 | |
| 0.678 | 0.007 | 0.784 | Antioxidant | 0.784 0.004 CID_154699576 | CID_154699576 | |
| 0.673 | 0.003 | 0.673 | Beta tubulin antagonist | 0.098 0.023 CID_154699576 | ||
| 0.634 | 0.008 | 0.634 | Caspase 3 stimulant | 0.495 0.021 CID_154699576 | ||
| 0.618 | 0.012 | 0.618 | 12-Lipoxygenase inhibitor | |||
| 0.617 | 0.029 | 0.874 | Transcription factor NF kappa B inhibitor | 0.874 0.008 CID_154699576 | CID_154699576 | |
| 0.563 | 0.012 | 0.563 | Lipoxygenase inhibitor | |||
| 0.542 | 0.012 | 0.593 | Antiamyloidogenic | 0.593 0.008 CID_154699576 | CID_154699576 | |
| 0.529 | 0.007 | 0.529 | Peroxidase inhibitor | |||
| 0.527 | 0.023 | 0.54 | Vasodilator, peripheral | 0.54 0.022 CID_154699576 | CID_154699576 | |
| 0.529 | 0.028 | 0.689 | Cholesterol antagonist | 0.689 0.009 CID_154699576 | CID_154699576 | |
| 0.516 | 0.018 | 0.516 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.493 | 0.006 | 0.777 | Amylase inhibitor | 0.777 0.002 CID_154699576 | CID_154699576 | |
| 0.508 | 0.026 | 0.666 | Histamine release inhibitor | 0.666 0.006 CID_154699576 | CID_154699576 | |
| 0.496 | 0.016 | 0.706 | Vasodilator, coronary | 0.706 0.004 CID_154699576 | CID_154699576 | |
| 0.475 | 0.007 | 0.475 | Calcium channel activator | 0.284 0.109 CID_154699576 | ||
| 0.466 | 0.01 | 0.466 | P-glycoprotein inhibitor | 0.332 0.024 CID_154699576 | ||
| 0.485 | 0.03 | 0.485 | 5 Hydroxytryptamine release stimulant | 0.363 0.054 CID_154699576 | ||
| 0.457 | 0.006 | 0.457 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.456 | 0.009 | 0.588 | Melanin inhibitor | 0.588 0.004 CID_154699576 | CID_154699576 | |
| 0.452 | 0.009 | 0.722 | Monophenol monooxygenase inhibitor | 0.722 0.004 CID_154699576 | CID_154699576 | |
| 0.484 | 0.044 | 0.484 | 15-Lipoxygenase inhibitor | |||
| 0.446 | 0.014 | 0.446 | Pyruvate kinase inhibitor | |||
| 0.433 | 0.005 | 0.433 | Breast cancer-resistant protein inhibitor | |||
| 0.417 | 0.009 | 0.436 | Lipid peroxidase inhibitor | 0.436 0.008 CID_154699576 | CID_154699576 | |
| 0.426 | 0.023 | 0.678 | Tumour necrosis factor alpha release inhibitor | 0.678 0.005 CID_154699576 | CID_154699576 | |
| 0.408 | 0.005 | 0.408 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.482 | 0.086 | 0.731 | Alpha-glucosidase inhibitor | 0.731 0.028 CID_154699576 | CID_154699576 | |
| 0.399 | 0.003 | 0.399 | Keratolytic | 0.096 0.033 CID_154699576 | ||
| 0.4 | 0.005 | 0.4 | 5-Lipoxygenase inhibitor | |||
| 0.402 | 0.008 | 0.402 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.425 | 0.032 | 0.594 | Apoptosis antagonist | 0.594 0.01 CID_154699576 | CID_154699576 | |
| 0.39 | 0.005 | 0.39 | Cystathionine beta-synthase inhibitor | 0.296 0.01 CID_154699576 | ||
| 0.407 | 0.025 | 0.57 | Nitric oxide antagonist | 0.57 0.011 CID_154699576 | CID_154699576 | |
| 0.397 | 0.017 | 0.602 | Cyclic AMP phosphodiesterase inhibitor | 0.602 0.004 CID_154699576 | CID_154699576 | |
| 0.384 | 0.009 | 0.524 | Protein kinase stimulant | 0.524 0.004 CID_154699576 | CID_154699576 | |
| 0.401 | 0.028 | 0.401 | DNA damaging | 0.401 0.028 CID_154699576 | ||
| 0.376 | 0.008 | 0.376 | Amyloid beta precursor protein antagonist | 0.131 0.125 CID_154699576 | ||
| 0.369 | 0.003 | 0.369 | Toll-Like receptor 2 antagonist | 0.194 0.026 CID_154699576 | ||
| 0.366 | 0.005 | 0.366 | Succinate dehydrogenase inhibitor | 0.165 0.087 CID_154699576 | ||
| 0.394 | 0.039 | 0.394 | Aryl hydrocarbon receptor agonist | |||
| 0.351 | 0.004 | 0.351 | HIV-1 integrase (3'-Processing) inhibitor | 0.114 0.021 CID_154699576 | ||
| 0.412 | 0.071 | 0.527 | 5 Hydroxytryptamine release inhibitor | 0.527 0.025 CID_154699576 | CID_154699576 | |
| 0.377 | 0.037 | 0.377 | Hypoxia-inducible factor 1 alpha inhibitor | 0.351 0.044 CID_154699576 | ||
| 0.349 | 0.011 | 0.349 | Tumour necrosis factor antagonist | 0.183 0.064 CID_154699576 | ||
| 0.341 | 0.005 | 0.398 | Carbonic anhydrase XIII inhibitor | 0.398 0.004 CID_154699576 | CID_154699576 | |
| 0.335 | 0.005 | 0.335 | Carbonic anhydrase VI inhibitor | 0.146 0.021 CID_154699576 | ||
| 0.358 | 0.03 | 0.358 | Transcription factor STAT3 inhibitor | |||
| 0.342 | 0.015 | 0.517 | Interferon gamma antagonist | 0.517 0.005 CID_154699576 | CID_154699576 | |
| 0.33 | 0.006 | 0.33 | Carbonic anhydrase XV inhibitor | |||
| 0.337 | 0.013 | 0.406 | NOS3 expression enhancer | 0.406 0.008 CID_154699576 | CID_154699576 | |
| 0.325 | 0.009 | 0.325 | Chelator | 0.106 0.069 CID_154699576 | ||
| 0.34 | 0.025 | 0.374 | Anesthetic general | 0.374 0.02 CID_154699576 | CID_154699576 | |
| 0.331 | 0.017 | 0.501 | DNA methyltransferase I inhibitor | 0.501 0.005 CID_154699576 | CID_154699576 | |
| 0.375 | 0.061 | 0.375 | Angiogenesis inhibitor | 0.372 0.062 CID_154699576 | ||
| 0.317 | 0.005 | 0.317 | Carbonic anhydrase III inhibitor | 0.175 0.021 CID_154699576 | ||
| 0.327 | 0.017 | 0.327 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.262 0.037 CID_154699576 | ||
| 0.353 | 0.052 | 0.483 | Spasmolytic | 0.483 0.025 CID_154699576 | CID_154699576 | |
| 0.336 | 0.039 | 0.336 | Transcription factor STAT inhibitor | |||
| 0.301 | 0.005 | 0.301 | HIV-1 integrase (Strand Transfer) inhibitor | 0.101 0.022 CID_154699576 | ||
| 0.304 | 0.01 | 0.304 | Nitric-oxide synthase stimulant | 0.297 0.012 CID_154699576 | ||
| 0.315 | 0.024 | 0.497 | DNA methylase inhibitor | 0.497 0.005 CID_154699576 | CID_154699576 | |
| 0.325 | 0.037 | 0.443 | Interleukin agonist | 0.443 0.014 CID_154699576 | CID_154699576 | |
| 0.301 | 0.014 | 0.301 | Cyclooxygenase 1 inhibitor | 0.165 0.049 CID_154699576 | ||
| 0.351 | 0.064 | 0.763 | Antithrombotic | 0.763 0.005 CID_154699576 | CID_154699576 | |
| 0.31 | 0.026 | 0.61 | Non-steroidal antiinflammatory agent | 0.61 0.004 CID_154699576 | CID_154699576 | |
| 0.287 | 0.007 | 0.287 | Histidine decarboxylase inhibitor | |||
| 0.305 | 0.028 | 0.571 | Hepatoprotectant | 0.571 0.005 CID_154699576 | CID_154699576 | |
| 0.284 | 0.013 | 0.284 | Cholesterol synthesis inhibitor | 0.178 0.033 CID_154699576 | ||
| 0.314 | 0.044 | 0.44 | Vasodilator | 0.44 0.017 CID_154699576 | CID_154699576 | |
| 0.406 | 0.136 | 0.795 | Antiinflammatory | 0.795 0.016 CID_154699576 | CID_154699576 | |
| 0.326 | 0.057 | 0.326 | Sodium/bile acid cotransporter inhibitor | 0.228 0.153 CID_154699576 | ||
| 0.319 | 0.051 | 0.319 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.303 | 0.038 | 0.303 | Sigma receptor agonist | |||
| 0.273 | 0.01 | 0.672 | Expectorant | 0.672 0.002 CID_154699576 | CID_154699576 | |
| 0.284 | 0.023 | 0.294 | Neurotrophic factor enhancer | 0.294 0.02 CID_154699576 | CID_154699576 | |
| 0.345 | 0.088 | 0.345 | GABA C receptor rho-3 antagonist | |||
| 0.307 | 0.051 | 0.688 | Hypoglycemic | 0.688 0.005 CID_154699576 | CID_154699576 | |
| 0.265 | 0.01 | 0.414 | Xanthine oxidase inhibitor | 0.414 0.004 CID_154699576 | CID_154699576 | |
| 0.303 | 0.048 | 0.802 | Angiogenesis stimulant | 0.802 0.004 CID_154699576 | CID_154699576 | |
| 0.262 | 0.008 | 0.674 | Beta glucuronidase inhibitor | 0.674 0.003 CID_154699576 | CID_154699576 | |
| 0.29 | 0.037 | 0.477 | Platelet adhesion inhibitor | 0.477 0.006 CID_154699576 | CID_154699576 | |
| 0.255 | 0.005 | 0.255 | Vanilloid 1 agonist | 0.203 0.011 CID_154699576 | ||
| 0.278 | 0.033 | 0.278 | Dual specificity phosphatase 3 inhibitor | |||
| 0.302 | 0.057 | 0.302 | Insulysin inhibitor | |||
| 0.267 | 0.025 | 0.267 | MAO inhibitor | |||
| 0.263 | 0.026 | 0.263 | Cytidine deaminase inhibitor | |||
| 0.369 | 0.132 | 0.369 | DNA polymerase beta inhibitor | |||
| 0.245 | 0.013 | 0.245 | Mannose-6-phosphate isomerase inhibitor | 0.225 0.019 CID_154699576 | ||
| 0.27 | 0.04 | 0.27 | RNA-directed DNA polymerase inhibitor | 0.212 0.083 CID_154699576 | ||
| 0.241 | 0.011 | 0.256 | Microtubule formation inhibitor | 0.256 0.007 CID_154699576 | CID_154699576 | |
| 0.228 | 0.005 | 0.228 | Adenylate cyclase stimulant | 0.157 0.052 CID_154699576 | ||
| 0.315 | 0.095 | 0.315 | Prostaglandin dehydrogenase inhibitor | |||
| 0.227 | 0.007 | 0.227 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.227 | 0.009 | 0.253 | Mucolytic | 0.253 0.006 CID_154699576 | CID_154699576 | |
| 0.252 | 0.037 | 0.252 | Dual specificity phosphatase inhibitor | |||
| 0.22 | 0.006 | 0.22 | Macrophage migration inhibitory factor inhibitor | |||
| 0.242 | 0.029 | 0.242 | Histone acetyltransferase inhibitor | |||
| 0.234 | 0.023 | 0.234 | MAO A inhibitor | |||
| 0.327 | 0.116 | 0.664 | Antibacterial | 0.664 0.012 CID_154699576 | CID_154699576 | |
| 0.215 | 0.005 | 0.215 | Heat shock protein 70 antagonist | 0.208 0.005 CID_154699576 | ||
| 0.267 | 0.057 | 0.267 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.231 | 0.024 | 0.231 | Alkaline phosphatase inhibitor | 0.204 0.031 CID_154699576 | ||
| 0.345 | 0.14 | 0.345 | DNA directed DNA polymerase inhibitor | |||
| 0.245 | 0.04 | 0.245 | I kappa B kinase epsilon inhibitor | |||
| 0.232 | 0.027 | 0.324 | Topoisomerase II inhibitor | 0.324 0.015 CID_154699576 | CID_154699576 | |
| 0.243 | 0.039 | 0.243 | Insulin sensitizer | 0.208 0.065 CID_154699576 | ||
| 0.225 | 0.022 | 0.349 | ATPase inhibitor | 0.349 0.004 CID_154699576 | CID_154699576 | |
| 0.228 | 0.026 | 0.228 | Acetylcholinesterase inhibitor | |||
| 0.287 | 0.085 | 0.287 | Streptokinase A inhibitor | |||
| 0.228 | 0.026 | 0.228 | NADPH oxidase inhibitor | 0.18 0.041 CID_154699576 | ||
| 0.217 | 0.016 | 0.217 | Interleukin 1b antagonist | 0.154 0.037 CID_154699576 | ||
| 0.233 | 0.033 | 0.233 | Heat shock protein 90 alpha antagonist | |||
| 0.25 | 0.052 | 0.25 | ErbB-1 antagonist | |||
| 0.21 | 0.015 | 0.522 | Cyclooxygenase 3 inhibitor | 0.522 0.003 CID_154699576 | CID_154699576 | |
| 0.235 | 0.041 | 0.235 | Mcl-1 antagonist | |||
| 0.214 | 0.021 | 0.214 | Arachidonic acid antagonist | 0.141 0.099 CID_154699576 | ||
| 0.214 | 0.024 | 0.214 | DNA polymerase I inhibitor | 0.189 0.032 CID_154699576 | ||
| 0.222 | 0.033 | 0.222 | Phospholipase C inhibitor | 0.165 0.08 CID_154699576 | ||
| 0.196 | 0.009 | 0.196 | Thioredoxin inhibitor | 0.19 0.009 CID_154699576 | ||
| 0.221 | 0.034 | 0.221 | Cyclooxygenase inhibitor | 0.137 0.081 CID_154699576 | ||
| 0.194 | 0.007 | 0.194 | Vanilloid agonist | 0.082 0.064 CID_154699576 | ||
| 0.208 | 0.023 | 0.208 | MAO B inhibitor | |||
| 0.189 | 0.005 | 0.189 | Histone deacetylase SIRT1 stimulant | 0.185 0.005 CID_154699576 | ||
| 0.189 | 0.005 | 0.189 | Histone deacetylase stimulant | 0.185 0.005 CID_154699576 | ||
| 0.19 | 0.009 | 0.19 | Electron transport complex I inhibitor | 0.114 0.055 CID_154699576 | ||
| 0.211 | 0.031 | 0.395 | Alpha-N-acetylglucosaminidase inhibitor | 0.395 0.009 CID_154699576 | CID_154699576 | |
| 0.188 | 0.009 | 0.188 | DOPA decarboxylase inhibitor | |||
| 0.194 | 0.016 | 0.253 | Topoisomerase II alpha inhibitor | 0.253 0.01 CID_154699576 | CID_154699576 | |
| 0.23 | 0.052 | 0.23 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.21 | 0.033 | 0.21 | Heat shock protein 90 antagonist | |||
| 0.184 | 0.008 | 0.184 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.205 | 0.031 | 0.205 | Interleukin 1 antagonist | |||
| 0.193 | 0.019 | 0.193 | Bronchodilator | 0.127 0.041 CID_154699576 | ||
| 0.316 | 0.146 | 0.316 | Transcription factor inhibitor | |||
| 0.181 | 0.015 | 0.181 | TRPA1 agonist | 0.127 0.05 CID_154699576 | ||
| 0.194 | 0.03 | 0.194 | Neurotrophic factor | 0.136 0.073 CID_154699576 | ||
| 0.198 | 0.036 | 0.198 | Neurotensin receptor agonist | |||
| 0.177 | 0.016 | 0.177 | Multidrug resistance-associated protein 1 inhibitor | 0.168 0.018 CID_154699576 | ||
| 0.194 | 0.033 | 0.194 | Toll-Like receptor antagonist | |||
| 0.197 | 0.037 | 0.346 | Hexokinase inhibitor | 0.346 0.006 CID_154699576 | CID_154699576 | |
| 0.163 | 0.004 | 0.163 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.184 | 0.028 | 0.184 | Interleukin 4 antagonist | 0.148 0.052 CID_154699576 | ||
| 0.172 | 0.018 | 0.172 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.223 | 0.073 | 0.413 | Peptidyltransferase inhibitor | 0.413 0.006 CID_154699576 | CID_154699576 | |
| 0.161 | 0.012 | 0.161 | Carbonic anhydrase V inhibitor | |||
| 0.167 | 0.018 | 0.167 | Estrogen antagonist | |||
| 0.177 | 0.03 | 0.177 | Antibacterial (Helicobacter pylori) | 0.111 0.096 CID_154699576 | ||
| 0.156 | 0.009 | 0.156 | Ornithine decarboxylase inhibitor | 0.119 0.026 CID_154699576 | ||
| 0.162 | 0.015 | 0.194 | Toll-Like receptor 4 antagonist | 0.194 0.007 CID_154699576 | CID_154699576 | |
| 0.164 | 0.019 | 0.164 | Creatine kinase inhibitor | |||
| 0.169 | 0.029 | 0.174 | Beta amyloid protein antagonist | 0.174 0.026 CID_154699576 | CID_154699576 | |
| 0.149 | 0.009 | 0.149 | HIV-1 integrase inhibitor | |||
| 0.191 | 0.05 | 0.191 | Protein-tyrosine phosphatase inhibitor | 0.158 0.071 CID_154699576 | ||
| 0.162 | 0.022 | 0.162 | Ca2+-transporting ATPase inhibitor | 0.156 0.029 CID_154699576 | ||
| 0.226 | 0.087 | 0.4 | DNA synthesis inhibitor | 0.4 0.021 CID_154699576 | CID_154699576 | |
| 0.18 | 0.042 | 0.18 | GABA C receptor rho-2 antagonist | |||
| 0.176 | 0.04 | 0.176 | CF transmembrane conductance regulator agonist | |||
| 0.297 | 0.16 | 0.297 | Calcium channel L-type activator | |||
| 0.157 | 0.021 | 0.157 | Calcium antagonist | |||
| 0.146 | 0.012 | 0.146 | Carbonic anhydrase VA inhibitor | |||
| 0.158 | 0.025 | 0.406 | Mediator release inhibitor | 0.406 0.005 CID_154699576 | CID_154699576 | |
| 0.157 | 0.024 | 0.157 | Catalase inhibitor | |||
| 0.136 | 0.004 | 0.136 | Catechol O-methyltransferase inhibitor | |||
| 0.172 | 0.04 | 0.172 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.143 | 0.012 | 0.143 | Myeloperoxidase inhibitor | |||
| 0.144 | 0.014 | 0.144 | Glutamate decarboxylase inhibitor | |||
| 0.169 | 0.042 | 0.169 | Cyclooxygenase 2 inhibitor | 0.109 0.093 CID_154699576 | ||
| 0.164 | 0.036 | 0.277 | Topoisomerase I inhibitor | 0.277 0.013 CID_154699576 | CID_154699576 | |
| 0.164 | 0.04 | 0.321 | Alkylator | 0.321 0.011 CID_154699576 | CID_154699576 | |
| 0.149 | 0.025 | 0.151 | Sphingomyelinase inhibitor | 0.151 0.024 CID_154699576 | CID_154699576 | |
| 0.127 | 0.004 | 0.143 | Glucose-6-phosphate translocase inhibitor | 0.143 0.004 CID_154699576 | CID_154699576 | |
| 0.127 | 0.007 | 0.127 | Estrogen-related receptor beta agonist | |||
| 0.132 | 0.013 | 0.132 | Thioredoxin reductase inhibitor | 0.081 0.058 CID_154699576 | ||
| 0.129 | 0.01 | 0.129 | Purinergic P2X1 antagonist | 0.068 0.034 CID_154699576 | ||
| 0.144 | 0.026 | 0.144 | Urease inhibitor | |||
| 0.127 | 0.01 | 0.127 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.091 0.02 CID_154699576 | ||
| 0.136 | 0.02 | 0.136 | Estrogen receptor beta antagonist | |||
| 0.197 | 0.081 | 0.202 | Psychostimulant | 0.202 0.079 CID_154699576 | CID_154699576 | |
| 0.149 | 0.034 | 0.149 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.198 | 0.083 | 0.198 | Platelet aggregation inhibitor | |||
| 0.147 | 0.034 | 0.147 | Protein kinase C gamma inhibitor | |||
| 0.138 | 0.026 | 0.141 | Acetylcholine release stimulant | 0.141 0.023 CID_154699576 | CID_154699576 | |
| 0.116 | 0.004 | 0.116 | Transcription factor RelA inhibitor | |||
| 0.147 | 0.034 | 0.247 | DNA repair enzyme inhibitor | 0.247 0.005 CID_154699576 | CID_154699576 | |
| 0.155 | 0.043 | 0.155 | Protein-tyrosine phosphatase 1B inhibitor | 0.155 0.044 CID_154699576 | ||
| 0.12 | 0.008 | 0.12 | GABA B receptor agonist | |||
| 0.119 | 0.008 | 0.119 | Aryl hydrocarbon receptor antagonist | |||
| 0.123 | 0.012 | 0.123 | Carbonic anhydrase VB inhibitor | |||
| 0.138 | 0.027 | 0.138 | Prolactin inhibitor | |||
| 0.135 | 0.027 | 0.135 | Phosphodiesterase IV inhibitor | |||
| 0.114 | 0.008 | 0.165 | Carbonic anhydrase XIV inhibitor | 0.165 0.005 CID_154699576 | CID_154699576 | |
| 0.12 | 0.014 | 0.12 | D-Ala-D-Ala ligase inhibitor | |||
| 0.237 | 0.132 | 0.237 | Thyroid hormone antagonist | |||
| 0.129 | 0.024 | 0.24 | NADH dehydrogenase inhibitor | 0.24 0.008 CID_154699576 | CID_154699576 | |
| 0.109 | 0.005 | 0.109 | Heme oxygenase stimulant | 0.071 0.024 CID_154699576 | ||
| 0.115 | 0.012 | 0.115 | Xanthine dehydrogenase inhibitor | |||
| 0.197 | 0.094 | 0.197 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.121 | 0.019 | 0.14 | ATPase (Vacuolar H+) inhibitor | 0.14 0.01 CID_154699576 | CID_154699576 | |
| 0.139 | 0.038 | 0.139 | Butyrylcholinesterase inhibitor | |||
| 0.114 | 0.014 | 0.114 | Elastase 1 inhibitor | |||
| 0.135 | 0.035 | 0.315 | UDP-glucose 4-epimerase inhibitor | 0.315 0.009 CID_154699576 | CID_154699576 | |
| 0.172 | 0.072 | 0.172 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.118 | 0.019 | 0.118 | Estrogen receptor alpha antagonist | |||
| 0.137 | 0.039 | 0.137 | GABA C receptor agonist | |||
| 0.115 | 0.018 | 0.115 | GABA aminotransferase inhibitor | 0.097 0.029 CID_154699576 | ||
| 0.135 | 0.038 | 0.351 | AMP-activated protein kinase stimulant | 0.351 0.004 CID_154699576 | CID_154699576 | |
| 0.228 | 0.132 | 0.228 | Thyroid hormone beta antagonist | |||
| 0.12 | 0.024 | 0.12 | Inducible nitric-oxide synthase inhibitor | |||
| 0.238 | 0.143 | 0.238 | Thioredoxin glutathione reductase inhibitor | |||
| 0.105 | 0.01 | 0.105 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.11 | 0.016 | 0.135 | Aldose reductase inhibitor | 0.135 0.012 CID_154699576 | CID_154699576 | |
| 0.108 | 0.016 | 0.108 | Alcohol oxidase inhibitor | |||
| 0.134 | 0.043 | 0.198 | Photosensitizer | 0.198 0.013 CID_154699576 | CID_154699576 | |
| 0.143 | 0.051 | 0.143 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.095 | 0.004 | 0.095 | Dopamine D5 agonist | |||
| 0.107 | 0.019 | 0.107 | Leukotriene antagonist | 0.091 0.026 CID_154699576 | ||
| 0.202 | 0.115 | 0.202 | Neuropeptide Y2 antagonist | |||
| 0.242 | 0.155 | 0.518 | Immunosuppressant | 0.518 0.028 CID_154699576 | CID_154699576 | |
| 0.093 | 0.006 | 0.093 | Vanilloid 2 antagonist | |||
| 0.134 | 0.05 | 0.134 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.144 | 0.06 | 0.144 | Farnesoid X receptor antagonist | |||
| 0.116 | 0.032 | 0.149 | Interleukin 12 antagonist | 0.149 0.013 CID_154699576 | CID_154699576 | |
| 0.122 | 0.038 | 0.122 | Anabolic | |||
| 0.114 | 0.031 | 0.166 | Phosphodiesterase 6D inhibitor | 0.166 0.007 CID_154699576 | CID_154699576 | |
| 0.09 | 0.009 | 0.09 | Calcium channel P-type blocker | |||
| 0.106 | 0.025 | 0.106 | CDC25A inhibitor | |||
| 0.12 | 0.039 | 0.186 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.186 0.018 CID_154699576 | CID_154699576 | |
| 0.098 | 0.018 | 0.098 | Estrogen agonist | 0.072 0.025 CID_154699576 | ||
| 0.086 | 0.006 | 0.086 | Ryanodine receptor antagonist | |||
| 0.087 | 0.008 | 0.087 | Squalene epoxidase inhibitor | 0.047 0.04 CID_154699576 | ||
| 0.09 | 0.011 | 0.09 | Topoisomerase II beta inhibitor | 0.055 0.026 CID_154699576 | ||
| 0.103 | 0.024 | 0.103 | Dopamine D1 antagonist | |||
| 0.151 | 0.073 | 0.151 | Phospholipase A2 inhibitor | 0.125 0.108 CID_154699576 | ||
| 0.114 | 0.037 | 0.114 | Protein kinase C zeta inhibitor | |||
| 0.195 | 0.118 | 0.195 | Calpain inhibitor | |||
| 0.109 | 0.033 | 0.109 | Bile acid receptor antagonist | |||
| 0.092 | 0.017 | 0.092 | Beta 3 adrenoreceptor antagonist | |||
| 0.151 | 0.077 | 0.151 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.106 | 0.033 | 0.106 | Porphobilinogen synthase inhibitor | |||
| 0.125 | 0.052 | 0.125 | Transcription factor STAT6 inhibitor | |||
| 0.131 | 0.059 | 0.131 | Anesthetic local | |||
| 0.181 | 0.11 | 0.181 | Dyrk kinase inhibitor | |||
| 0.074 | 0.004 | 0.074 | CYP24 inhibitor | 0.022 0.017 CID_154699576 | ||
| 0.09 | 0.021 | 0.09 | Beta adrenoreceptor antagonist | |||
| 0.123 | 0.054 | 0.123 | Polo-like kinase-4 inhibitor | |||
| 0.131 | 0.062 | 0.131 | Cathepsin H inhibitor | |||
| 0.13 | 0.062 | 0.14 | Aldehyde dehydrogenase inhibitor | 0.14 0.054 CID_154699576 | CID_154699576 | |
| 0.147 | 0.079 | 0.147 | Cholinergic | |||
| 0.115 | 0.047 | 0.115 | Gastric antisecretory | |||
| 0.102 | 0.036 | 0.102 | Phosphodiesterase 4D inhibitor | |||
| 0.079 | 0.013 | 0.079 | Carbonic anhydrase VII inhibitor | 0.045 0.034 CID_154699576 | ||
| 0.069 | 0.004 | 0.069 | Vanilloid 3 antagonist | |||
| 0.092 | 0.026 | 0.092 | Glycine receptor agonist | 0.08 0.038 CID_154699576 | ||
| 0.085 | 0.02 | 0.085 | Exportin-1 inhibitor | |||
| 0.117 | 0.052 | 0.117 | Alpha 2c adrenoreceptor antagonist | |||
| 0.074 | 0.01 | 0.074 | Pregnane X receptor antagonist | |||
| 0.094 | 0.03 | 0.094 | Leukotriene synthesis inhibitor | |||
| 0.088 | 0.024 | 0.088 | Aromatase inhibitor | |||
| 0.087 | 0.023 | 0.087 | Potassium channel (ATP-sensitive) blocker | |||
| 0.101 | 0.037 | 0.101 | Glutathione S-transferase inhibitor | |||
| 0.083 | 0.019 | 0.083 | Transcription factor AP-1 inhibitor | 0.075 0.025 CID_154699576 | ||
| 0.074 | 0.013 | 0.074 | Estrogen receptor alpha agonist | |||
| 0.101 | 0.041 | 0.111 | Glutamate release inhibitor | 0.111 0.029 CID_154699576 | CID_154699576 | |
| 0.071 | 0.011 | 0.071 | Adenylate cyclase 1 inhibitor | |||
| 0.12 | 0.06 | 0.12 | Caspase 3 inhibitor | |||
| 0.14 | 0.08 | 0.14 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.083 | 0.024 | 0.083 | Glutamate (mGluR7) antagonist | |||
| 0.165 | 0.107 | 0.165 | Interleukin antagonist | |||
| 0.069 | 0.011 | 0.072 | Factor III inhibitor | 0.072 0.01 CID_154699576 | CID_154699576 | |
| 0.075 | 0.017 | 0.109 | Leukotriene B4 antagonist | 0.109 0.009 CID_154699576 | CID_154699576 | |
| 0.091 | 0.034 | 0.091 | Purinergic P2X2 antagonist | |||
| 0.102 | 0.046 | 0.218 | Triose-phosphate isomerase inhibitor | 0.218 0.009 CID_154699576 | CID_154699576 | |
| 0.082 | 0.026 | 0.082 | 5 Hydroxytryptamine 2A agonist | |||
| 0.106 | 0.049 | 0.106 | Glutamate (mGluR7) agonist | |||
| 0.122 | 0.066 | 0.122 | Adenylate cyclase inhibitor | |||
| 0.131 | 0.075 | 0.131 | Bone formation stimulant | 0.106 0.099 CID_154699576 | ||
| 0.077 | 0.021 | 0.077 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.202 | 0.147 | 0.202 | Gastrin inhibitor | |||
| 0.105 | 0.051 | 0.105 | Potassium channel (Ca-activated) activator | |||
| 0.061 | 0.007 | 0.061 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.075 | 0.021 | 0.075 | Beta 1 adrenoreceptor antagonist | |||
| 0.134 | 0.081 | 0.134 | Activin receptor-like kinase 2 inhibitor | |||
| 0.064 | 0.01 | 0.064 | Estrogen-related receptor alpha antagonist | |||
| 0.131 | 0.079 | 0.131 | Nav1.6 sodium channel blocker | |||
| 0.091 | 0.04 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.116 0.019 CID_154699576 | CID_154699576 | |
| 0.06 | 0.01 | 0.06 | Dihydrofolate reductase inhibitor | |||
| 0.076 | 0.026 | 0.076 | Maillard reaction inhibitor | |||
| 0.055 | 0.006 | 0.055 | Tubulin agonist | 0.038 0.017 CID_154699576 | ||
| 0.061 | 0.014 | 0.061 | Dopamine beta hydroxylase inhibitor | |||
| 0.054 | 0.006 | 0.054 | NMDA 2D receptor antagonist | |||
| 0.135 | 0.088 | 0.412 | Hemostatic | 0.412 0.007 CID_154699576 | CID_154699576 | |
| 0.066 | 0.019 | 0.066 | Leukotriene C antagonist | |||
| 0.131 | 0.084 | 0.272 | Cell wall synthesis inhibitor | 0.272 0.012 CID_154699576 | CID_154699576 | |
| 0.063 | 0.017 | 0.063 | Estrogen receptor beta agonist | |||
| 0.066 | 0.021 | 0.066 | Dihydroorotate oxidase inhibitor | |||
| 0.063 | 0.017 | 0.063 | Glutamate (mGluR group III) agonist | |||
| 0.054 | 0.01 | 0.054 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.082 | 0.038 | 0.094 | Phosphodiesterase VI inhibitor | 0.094 0.025 CID_154699576 | CID_154699576 | |
| 0.071 | 0.027 | 0.071 | Heat shock protein 90 beta antagonist | |||
| 0.125 | 0.081 | 0.125 | Toll-Like receptor 9 antagonist | |||
| 0.065 | 0.021 | 0.065 | Plasminogen activator inhibitor antagonist | |||
| 0.102 | 0.059 | 0.102 | GABA C receptor rho-1 antagonist | |||
| 0.062 | 0.02 | 0.062 | Potassium channel Kv1.3 blocker | |||
| 0.055 | 0.013 | 0.055 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.066 | 0.024 | 0.066 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.082 | 0.041 | 0.082 | MAP kinase kinase 7 inhibitor | |||
| 0.171 | 0.131 | 0.171 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.062 | 0.022 | 0.062 | Beta 2 adrenoreceptor antagonist | |||
| 0.052 | 0.012 | 0.052 | Kainate receptor agonist | |||
| 0.132 | 0.093 | 0.132 | Pregnane X receptor agonist | |||
| 0.107 | 0.068 | 0.107 | GABA C receptor antagonist | |||
| 0.111 | 0.073 | 0.111 | Proteasome inhibitor | |||
| 0.059 | 0.024 | 0.22 | Heparanase inhibitor | 0.22 0.002 CID_154699576 | CID_154699576 | |
| 0.094 | 0.059 | 0.094 | Alcohol dehydrogenase inhibitor | 0.083 0.074 CID_154699576 | ||
| 0.077 | 0.043 | 0.168 | Phosphofructokinase-1 inhibitor | 0.168 0.015 CID_154699576 | CID_154699576 | |
| 0.1 | 0.067 | 0.1 | Adenylate kinase inhibitor | |||
| 0.089 | 0.056 | 0.089 | Alpha 2 adrenoreceptor antagonist | |||
| 0.097 | 0.064 | 0.097 | Nitric-oxide synthase inhibitor | |||
| 0.052 | 0.019 | 0.063 | Guanylate cyclase inhibitor | 0.063 0.009 CID_154699576 | CID_154699576 | |
| 0.07 | 0.038 | 0.07 | CDC25B inhibitor | |||
| 0.061 | 0.029 | 0.061 | Phosphodiesterase 4A inhibitor | |||
| 0.065 | 0.034 | 0.065 | Cyclin D1 inhibitor | |||
| 0.045 | 0.016 | 0.045 | Glutamate (mGluR8) agonist | |||
| 0.064 | 0.035 | 0.064 | Beta 2 adrenoreceptor agonist | |||
| 0.138 | 0.11 | 0.198 | Interleukin 6 antagonist | 0.198 0.042 CID_154699576 | CID_154699576 | |
| 0.087 | 0.059 | 0.087 | Insulin growth factor antagonist | |||
| 0.044 | 0.017 | 0.044 | Phosphoglycerate kinase inhibitor | |||
| 0.053 | 0.026 | 0.079 | Glucose-6-phosphate isomerase inhibitor | 0.079 0.009 CID_154699576 | CID_154699576 | |
| 0.058 | 0.031 | 0.058 | Lysine-specific demethylase 1A inhibitor | |||
| 0.084 | 0.058 | 0.084 | mTOR complex 2 inhibitor | |||
| 0.076 | 0.051 | 0.076 | Alpha 2a adrenoreceptor antagonist | |||
| 0.274 | 0.249 | 0.274 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.066 | 0.041 | 0.112 | Neuraminidase (influenza) inhibitor | 0.112 0.013 CID_154699576 | CID_154699576 | |
| 0.049 | 0.025 | 0.049 | Dihydroorotase inhibitor | |||
| 0.057 | 0.034 | 0.071 | Adenine nucleotide translocase inhibitor | 0.071 0.014 CID_154699576 | CID_154699576 | |
| 0.099 | 0.076 | 0.099 | Alpha 2b adrenoreceptor antagonist | |||
| 0.057 | 0.035 | 0.057 | Sphingosine kinase 2 inhibitor | |||
| 0.033 | 0.011 | 0.033 | Estrogen-related receptor gamma antagonist | |||
| 0.061 | 0.039 | 0.061 | Biliverdin reductase inhibitor | |||
| 0.116 | 0.094 | 0.116 | Cytokine production inhibitor | |||
| 0.045 | 0.024 | 0.045 | Liver X receptor alpha agonist | |||
| 0.041 | 0.021 | 0.041 | Leukotriene C4 antagonist | |||
| 0.252 | 0.231 | 0.252 | MAP kinase 1 inhibitor | |||
| 0.053 | 0.033 | 0.053 | Aconitate hydratase inhibitor | |||
| 0.035 | 0.016 | 0.035 | Glutamate (mGluR3) agonist | |||
| 0.095 | 0.076 | 0.095 | Falcipain 3 inhibitor | |||
| 0.095 | 0.077 | 0.095 | Ferrochelatase inhibitor | |||
| 0.042 | 0.025 | 0.042 | Dihydropteroate synthase inhibitor | |||
| 0.027 | 0.011 | 0.027 | Dopamine D1 agonist | 0.022 0.017 CID_154699576 | ||
| 0.041 | 0.025 | 0.041 | Alpha 1d adrenoreceptor agonist | |||
| 0.08 | 0.065 | 0.08 | Androgen antagonist | |||
| 0.029 | 0.015 | 0.029 | Hedgehog signaling activator | |||
| 0.03 | 0.015 | 0.03 | Leukotriene D4 antagonist | |||
| 0.085 | 0.071 | 0.085 | Polo-like kinase-1 inhibitor | |||
| 0.027 | 0.013 | 0.027 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.094 | 0.08 | 0.169 | DNA intercalator | 0.169 0.035 CID_154699576 | CID_154699576 | |
| 0.022 | 0.008 | 0.036 | Antibiotic Anthracycline-like | 0.036 0.003 CID_154699576 | CID_154699576 | |
| 0.141 | 0.128 | 0.141 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.059 | 0.045 | 0.059 | TRPA1 antagonist | |||
| 0.028 | 0.015 | 0.028 | Prostaglandin H2 antagonist | |||
| 0.076 | 0.063 | 0.076 | Phosphodiesterase 3A inhibitor | |||
| 0.037 | 0.025 | 0.037 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.056 | 0.044 | 0.056 | Botulinum neurotoxin type A inhibitor | |||
| 0.023 | 0.011 | 0.023 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.038 | 0.026 | 0.038 | Farnesoid X receptor agonist | |||
| 0.028 | 0.016 | 0.112 | Sodium/glucose cotransporter 2 inhibitor | 0.112 0.002 CID_154699576 | CID_154699576 | |
| 0.069 | 0.057 | 0.069 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.032 | 0.021 | 0.032 | ATP citrate lysase inhibitor | |||
| 0.045 | 0.034 | 0.045 | Glycine transporter 2 inhibitor | |||
| 0.026 | 0.016 | 0.026 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.071 | 0.061 | 0.071 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.14 | 0.131 | 0.14 | Catenin beta inhibitor | |||
| 0.076 | 0.067 | 0.076 | Insulin like growth factor 1 antagonist | |||
| 0.028 | 0.019 | 0.032 | Uridine phosphorylase inhibitor | 0.032 0.016 CID_154699576 | CID_154699576 | |
| 0.029 | 0.021 | 0.029 | Liver X receptor alpha antagonist | |||
| 0.039 | 0.031 | 0.039 | Histone deacetylase 8 inhibitor | |||
| 0.014 | 0.007 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.037 | 0.03 | 0.037 | Retinoic acid alpha receptor agonist | |||
| 0.042 | 0.036 | 0.042 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.047 | 0.04 | 0.047 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.031 | 0.025 | 0.031 | Estrogen-related receptor beta antagonist | |||
| 0.05 | 0.044 | 0.103 | Alpha-mannosidase inhibitor | 0.103 0.006 CID_154699576 | CID_154699576 | |
| 0.025 | 0.019 | 0.099 | Sodium/glucose cotransporter inhibitor | 0.099 0.003 CID_154699576 | CID_154699576 | |
| 0.101 | 0.096 | 0.101 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.022 | 0.016 | 0.022 | Vitamin D receptor antagonist | 0.022 0.015 CID_154699576 | ||
| 0.032 | 0.027 | 0.032 | Glutamate (mGluR4) agonist | |||
| 0.054 | 0.05 | 0.054 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.052 | 0.048 | 0.052 | 5 Hydroxytryptamine 7 agonist | |||
| 0.033 | 0.029 | 0.033 | Adenosine uptake inhibitor | |||
| 0.024 | 0.021 | 0.038 | Vanilloid 2 agonist | 0.038 0.004 CID_154699576 | CID_154699576 | |
| 0.052 | 0.049 | 0.067 | Prostaglandin EP2 antagonist | 0.067 0.035 CID_154699576 | CID_154699576 | |
| 0.118 | 0.115 | 0.288 | Insulin secretagoues | 0.288 0.014 CID_154699576 | CID_154699576 | |
| 0.006 | 0.004 | 0.006 | Insulin like growth factor 3 antagonist | |||
| 0.034 | 0.031 | 0.034 | Diamine oxidase inhibitor | |||
| 0.046 | 0.044 | 0.046 | CD45 antagonist | |||
| 0.054 | 0.052 | 0.094 | Neuraminidase inhibitor | 0.094 0.018 CID_154699576 | CID_154699576 | |
| 0.071 | 0.07 | 0.071 | Adrenaline agonist | |||
| 0.062 | 0.06 | 0.062 | Glutamate (mGluR6) antagonist | |||
| 0.153 | 0.152 | 0.445 | Immunostimulant | 0.445 0.038 CID_154699576 | CID_154699576 | |
| 0.066 | 0.065 | 0.066 | Metalloproteinase-9 inhibitor | |||
| 0.067 | 0.067 | 0.242 | Antineoplastic antibiotic | 0.242 0.015 CID_154699576 | CID_154699576 | |
| 0.096 | 0.098 | 0.347 | Cell adhesion inhibitor | 0.347 0.007 CID_154699576 | CID_154699576 | |
| 0.048 | 0.052 | 0.055 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.055 0.04 CID_154699576 | CID_154699576 | |
| 0.013 | 0.018 | 0.039 | Ileal bile acid transport inhibitor | 0.039 0.004 CID_154699576 | CID_154699576 | |
| 0.017 | 0.027 | 0.021 | Leukotriene B4 receptor 2 antagonist | 0.021 0.017 CID_154699576 | CID_154699576 | |
| 0.078 | 0.089 | 0.122 | Uric acid excretion stimulant | 0.122 0.037 CID_154699576 | CID_154699576 | |
| 0.007 | 0.018 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 CID_154699576 | CID_154699576 | |
| 0.013 | 0.024 | 0.018 | Telomerase stimulant | 0.018 0.01 CID_154699576 | CID_154699576 | |
| 0.036 | 0.049 | 0.1 | Mannosidase inhibitor | 0.1 0.006 CID_154699576 | CID_154699576 | |
| 0.067 | 0.082 | 0.123 | Glycine receptor antagonist | 0.123 0.016 CID_154699576 | CID_154699576 | |
| 0.048 | 0.074 | 0.084 | Nitric oxide donor | 0.084 0.019 CID_154699576 | CID_154699576 | |
| 0.021 | 0.049 | 0.039 | Toll-Like receptor 4 agonist | 0.039 0.005 CID_154699576 | CID_154699576 | |
| 0.069 | 0.102 | 0.17 | Transcription factor NF kappa B stimulant | 0.17 0.012 CID_154699576 | CID_154699576 | |
| 0.069 | 0.104 | 0.085 | Interleukin 5 antagonist | 0.085 0.063 CID_154699576 | CID_154699576 | |
| 0.031 | 0.072 | 0.054 | Microtubule stabilization | 0.054 0.023 CID_154699576 | CID_154699576 | |
| 0.124 | 0.169 | 0.315 | Hypolipemic | 0.315 0.044 CID_154699576 | CID_154699576 | |
| 0.01 | 0.06 | 0.048 | Squalene synthetase inhibitor | 0.048 0.015 CID_154699576 | CID_154699576 | |
| 0.02 | 0.076 | 0.044 | Carbonic anhydrase XII inhibitor | 0.044 0.042 CID_154699576 | CID_154699576 | |
| 0.09 | 0.147 | 0.356 | Thrombolytic | 0.356 0.016 CID_154699576 | CID_154699576 | |
| 0.021 | 0.089 | 0.059 | Phosphorylase inhibitor | 0.059 0.025 CID_154699576 | CID_154699576 | |
| 0.009 | 0.084 | 0.033 | Arginase inhibitor | 0.033 0.028 CID_154699576 | CID_154699576 | |
| 0.054 | 0.135 | 0.087 | Falcipain 2 inhibitor | 0.087 0.062 CID_154699576 | CID_154699576 | |
| 0.053 | 0.136 | 0.187 | Cell adhesion molecule inhibitor | 0.187 0.01 CID_154699576 | CID_154699576 | |
| 0.024 | 0.11 | 0.115 | Protein 50S ribosomal subunit inhibitor | 0.115 0.01 CID_154699576 | CID_154699576 | |
| 0.055 | 0.14 | 0.089 | Falcipain inhibitor | 0.089 0.063 CID_154699576 | CID_154699576 | |
| 0.043 | 0.131 | 0.066 | Lipocortins synthesis agonist | 0.066 0.026 CID_154699576 | CID_154699576 | |
| 0.023 | 0.114 | 0.055 | Neuraminidase (Influenza A) inhibitor | 0.055 0.017 CID_154699576 | CID_154699576 | |
| 0.027 | 0.119 | 0.365 | Selectin antagonist | 0.365 0.004 CID_154699576 | CID_154699576 | |
| 0.012 | 0.117 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.021 CID_154699576 | CID_154699576 | |
| 0.002 | 0.109 | 0.013 | Antibiotic Macrolide-like | 0.013 0.01 CID_154699576 | CID_154699576 | |
| 0.096 | 0.229 | 0.35 | Platelet antagonist | 0.35 0.038 CID_154699576 | CID_154699576 | |
| 0.01 | 0.159 | 0.055 | Protein 30S ribosomal subunit inhibitor | 0.055 0.007 CID_154699576 | CID_154699576 | |
| 0.019 | 0.17 | 0.08 | Antibiotic Aminoglycoside-like | 0.08 0.004 CID_154699576 | CID_154699576 | |
| 0.102 | 0.258 | 0.146 | CC chemokine 6 receptor antagonist | 0.146 0.028 CID_154699576 | CID_154699576 | |
| 0.059 | 0.223 | 0.088 | T cell inhibitor | 0.088 0.042 CID_154699576 | CID_154699576 | |
| 0.138 | 0.333 | 0.416 | Interleukin 2 agonist | 0.416 0.023 CID_154699576 | CID_154699576 | |
| 0.055 | 0.296 | 0.122 | Diuretic | 0.122 0.102 CID_154699576 | CID_154699576 | |
| 0.115 | 0.438 | 0.745 | Cyclophilin D inhibitor | 0.745 0.01 CID_154699576 | CID_154699576 | |
| 0.073 | 0.473 | 0.265 | Toll-Like receptor 7 agonist | 0.265 0.134 CID_154699576 | CID_154699576 | |
| 0.07 | 0.48 | 0.288 | Toll-Like receptor agonist | 0.288 0.118 CID_154699576 | CID_154699576 | |
| 0.015 | 0.566 | 0.071 | Factor IXa inhibitor | 0.071 0.02 CID_154699576 | CID_154699576 | |
| 0.01 | 0.68 | 0.21 | Anticoagulant | 0.21 0.049 CID_154699576 | CID_154699576 | |
| 0.023 | 0.778 | 0.337 | Immunomodulator | 0.337 0.064 CID_154699576 | CID_154699576 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |